AKT in cancer: new molecular insights and advances in drug developmentPrabhjot S. Mundi, Kevin Kalinsky, Jasgit C. Sachdev et al.|British Journal of Clinical Pharmacology|2016Cited by 267
Effect of Capivasertib in Patients With an <i>AKT1 E17K</i>-Mutated TumorKevin Kalinsky, Keith T. Flaherty, Fangxin Hong et al.|JAMA Oncology|2020Cited by 106
First-in-Human Study of PF-06647020 (Cofetuzumab Pelidotin), an Antibody–Drug Conjugate Targeting Protein Tyrosine Kinase 7, in Advanced Solid TumorsMichael L. Maitland, Emiliano Calvo, Allison Moreau et al.|Clinical Cancer Research|2021Cited by 81
Cardiotoxicity of Trastuzumab Treatment in African American Women and Older Women in the Non Trial Setting.Jessica N. Snider, Jasgit C. Sachdev, C. Paba et al.|Cancer Research|2009Cited by 2